Clinical trial
Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia With and Without Substitution of Immunoglobulin G: a Prospective Observational Study
NCT03357978 is registered in ClinicalTrials.gov with Johann Wolfgang Goethe University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Susceptibility to Infections, Tumor Risk and Liver Disease in Patients With Ataxia Telangiectasia With and Without Substitution of Immunoglobulin G: a Prospective Observational Study
- Lead sponsor
- Johann Wolfgang Goethe University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 1, 2016
- Completion date
- September 30, 2019
- Enrollment
- 30 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.